Startup | November 13, 2021
DawaDost rolls out diabetes medicine at Re 1 per day
The start-up has announced the scheme to mark World Diabetes Day
The start-up has announced the scheme to mark World Diabetes Day
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The company claims that its Empagliflozin tablets are the most affordable in India
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Results from year two of the pivotal Phase 3 KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one
Subscribe To Our Newsletter & Stay Updated
